Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
MAFLD is characterized by the abnormal accumulation of fat (steatosis) in the liver in the absence of heavy alcohol consumption and in the presence of obesity, type 2 diabetes mellitus, or metabolic dysregulation (92)
Its active ingredient, semaglutide, mimics a naturally occurring hormone in the body called GLP-1
Unlike surgical options, peptide therapy offers a minimally invasive, nonsurgical alternative to enhance the bodys natural healing processes
Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation
It helps detoxify, boost immunity, and protect against oxidative stress
doi: 10.3389/fcdhc.2022.968113 13 HarrisPATaylorRMinorBLElliottVFernandezMO'NealLet al
US$ 27.59
US$ 26.32
US$ 20.24
US$ 29.00
US$ 28.02
US$ 23.20
US$ 26.48
